Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients
Open Access
- 28 January 2022
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 578-588
Abstract
Background: Generally, little is known about prognostic factors in bladder cancer patients under 40 years of age. We therefore performed a retrospective study to identify prognostic factors in these younger bladder cancer patients. Methods: We collected clinicopathological data on bladder cancer patients ≤40 years old diagnosed between 1975 and 2018 from the Surveillance, Epidemiology, and End Results (SEER) database. Survival curves were generated using the Kaplan–Meier method, and the differences between groups were analyzed using the log-rank test. Univariate and multivariate Cox hazards regression analyses were performed to define hazard ratios (HRs) for cancer-specific survival (CSS). Results: There were statistical differences in race, histological type, cancer stage, tumor size, and surgery treatment groups between overall survival and CSS. Only tumor size and cancer stage were significant independent prognostic risk factors in younger bladder cancer patients for the prediction of CSS. Conclusion: Tumors greater than 30 mm in size and a more advanced stage of bladder cancer were indicative of a poor prognosis in bladder cancer patients ≤40 years old, and long-term follow-up is suggested.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder CancerClinical Genitourinary Cancer, 2020
- Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancerUrologic Oncology: Seminars and Original Investigations, 2020
- Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder CancerFrontiers in Oncology, 2019
- Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging ContextsClinical Genitourinary Cancer, 2017
- Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysisUrologic Oncology: Seminars and Original Investigations, 2016
- Comparison of SEER Treatment Data With Medicare ClaimsMedical Care, 2016
- Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related OutcomesUrology, 2016
- Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldVirchows Archiv, 2015
- Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse OutcomeEuropean Urology, 2010
- Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.Journal of Clinical Oncology, 1995